Mobile

Result of your search per sponsor: Bayer HealthCare AG, Leverkusen, D-51368 Germany

Woman Max 99 years
Bayer HealthCare AG, Leverkusen, D-51368 Germany Update Il y a 5 ans

A multi-center, open label, single-arm study to investigate the safety and efficacy of daily oral administration of 2 mg dienogest tablets for the treatment of endometriosis in adolescents over a treatment period of 52 weeks To demonstrate safety of dienogest (DNG) in the treatment of endometriosis in adolescents

  • Country None
  • organs None
  • Specialty None
Closed trial
More information